CN101679396B - 三唑基氨基嘧啶化合物 - Google Patents

三唑基氨基嘧啶化合物 Download PDF

Info

Publication number
CN101679396B
CN101679396B CN2008800159078A CN200880015907A CN101679396B CN 101679396 B CN101679396 B CN 101679396B CN 2008800159078 A CN2008800159078 A CN 2008800159078A CN 200880015907 A CN200880015907 A CN 200880015907A CN 101679396 B CN101679396 B CN 101679396B
Authority
CN
China
Prior art keywords
methyl
ethyl
fluoro
amino
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008800159078A
Other languages
English (en)
Chinese (zh)
Other versions
CN101679396A (zh
Inventor
H·B·布鲁克斯
J·Z·克里奇
J·R·亨利
胡红
蒋德炉
李宏宇
S·G·米尼尔
W·T·麦米伦
J·S·索耶
M·K·斯拉特
王延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN101679396A publication Critical patent/CN101679396A/zh
Application granted granted Critical
Publication of CN101679396B publication Critical patent/CN101679396B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN2008800159078A 2007-05-16 2008-05-07 三唑基氨基嘧啶化合物 Expired - Fee Related CN101679396B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93833307P 2007-05-16 2007-05-16
US60/938,333 2007-05-16
PCT/US2008/062799 WO2008144222A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (2)

Publication Number Publication Date
CN101679396A CN101679396A (zh) 2010-03-24
CN101679396B true CN101679396B (zh) 2012-06-06

Family

ID=39967594

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008800159078A Expired - Fee Related CN101679396B (zh) 2007-05-16 2008-05-07 三唑基氨基嘧啶化合物

Country Status (15)

Country Link
US (1) US8114872B2 (enExample)
EP (1) EP2155735A2 (enExample)
JP (1) JP5204838B2 (enExample)
KR (1) KR101131254B1 (enExample)
CN (1) CN101679396B (enExample)
AR (1) AR066472A1 (enExample)
AU (1) AU2008254318B2 (enExample)
BR (1) BRPI0811611A2 (enExample)
CA (1) CA2687474A1 (enExample)
CL (1) CL2008001322A1 (enExample)
EA (1) EA015574B1 (enExample)
MX (1) MX2009012233A (enExample)
PE (1) PE20090803A1 (enExample)
TW (1) TW200902012A (enExample)
WO (1) WO2008144222A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA016178B1 (ru) 2006-12-21 2012-02-28 Эли Лилли Энд Компани Соединения имидазолидинониламинопиримидина
ATE479680T1 (de) 2006-12-21 2010-09-15 Lilly Co Eli Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
EP2155735A2 (en) 2007-05-16 2010-02-24 Eli Lilly And Company Triazolyl aminopyrimidine compounds
TW200908981A (en) * 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds
US9730447B2 (en) 2013-04-15 2017-08-15 E I Du Pont De Nemours And Company Fungicidal amides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007599A2 (en) * 1988-02-09 1989-08-24 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2006066172A1 (en) * 2004-12-17 2006-06-22 Amgen, Inc. Aminopyrimidine compounds and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
WO2006021548A1 (de) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
EP2001480A4 (en) 2006-03-31 2011-06-15 Abbott Lab Indazole CONNECTIONS
ATE479680T1 (de) 2006-12-21 2010-09-15 Lilly Co Eli Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
EP2155735A2 (en) 2007-05-16 2010-02-24 Eli Lilly And Company Triazolyl aminopyrimidine compounds
TW200908981A (en) * 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007599A2 (en) * 1988-02-09 1989-08-24 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2006066172A1 (en) * 2004-12-17 2006-06-22 Amgen, Inc. Aminopyrimidine compounds and methods of use

Also Published As

Publication number Publication date
AR066472A1 (es) 2009-08-19
CA2687474A1 (en) 2008-11-27
CN101679396A (zh) 2010-03-24
AU2008254318A1 (en) 2008-11-27
EA015574B1 (ru) 2011-10-31
WO2008144222A2 (en) 2008-11-27
CL2008001322A1 (es) 2009-05-22
EA200971067A1 (ru) 2010-04-30
KR20090130246A (ko) 2009-12-21
BRPI0811611A2 (pt) 2014-11-04
WO2008144222A3 (en) 2009-01-15
AU2008254318B2 (en) 2012-04-05
TW200902012A (en) 2009-01-16
US8114872B2 (en) 2012-02-14
JP2010527364A (ja) 2010-08-12
EP2155735A2 (en) 2010-02-24
MX2009012233A (es) 2009-12-01
PE20090803A1 (es) 2009-07-11
JP5204838B2 (ja) 2013-06-05
US20100130466A1 (en) 2010-05-27
KR101131254B1 (ko) 2012-04-24

Similar Documents

Publication Publication Date Title
CN101679395B (zh) 三唑基氨基嘧啶化合物
TWI343383B (en) Pyrazole derivatives and uses thereof
CN105899490A (zh) 嘧啶fgfr4抑制剂
CN102317269A (zh) 新氨基氮杂杂环甲酰胺类
CN101679396B (zh) 三唑基氨基嘧啶化合物
CN105315285A (zh) 2,4-二取代7H-吡咯并[2,3-d]嘧啶衍生物、其制法与医药上的用途
CN101568539B (zh) 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
CN101370792A (zh) 激酶的联-芳基间-嘧啶抑制剂
CN101208332A (zh) 作为egf和/或erbb2受体酪氨酸激酶抑制剂的喹唑啉衍生物
CN103936762B (zh) 吗啉并喹啉类化合物，其制备方法和用途
CN101563342B (zh) 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
CN111170986A (zh) 布鲁顿酪氨酸激酶的抑制剂
HK1234036A1 (en) Fused pyrimidine compound, intermediate, preparation method therefor, composition and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120606

Termination date: 20150507

EXPY Termination of patent right or utility model